Novartis agrees U.S. label change for Gilenya

ZURICH (Reuters) - Novartis said it had agreed with the U.S. Food and Drug Administration on label changes for multiple sclerosis drug Gilenya to include a recommendation that patients are more closely monitored for heart problems. "The label...

Source: http://health.yahoo.net/news/s/nm/novartis-agrees-u-s-label-change-for-gilenya

funny UBS AG Netflix Scarlett Johansson